ATX-304 25MG + SLU-PP-332 15MG

ATX-304 + SLU-PP-332 | Research Compound Combination

Composition Per Capsule | 60 Capsules

ATX-304 (O-304) — 25 mg

SLU-PP-332 — 15 mg

ATX-304 and SLU-PP-332 are investigational small molecules studied in experimental models involving distinct aspects of cellular energy regulation and metabolic signaling.

ATX-304 (O-304)

ATX-304 is investigated as a pan-AMPK activator. AMPK is a cellular energy-sensing kinase involved in regulation of metabolic homeostasis, including glucose and lipid metabolism and cellular responses to energetic demand.

SLU-PP-332

SLU-PP-332 is an experimental estrogen-related receptor (ERR) agonist investigated in preclinical models. ERR signaling participates in transcriptional regulation of mitochondrial biogenesis, oxidative metabolism, and cellular energetic processes.

Research Context

The compounds involve distinct experimental targets—AMPK-associated signaling for ATX-304 and ERR-mediated transcriptional signaling for SLU-PP-332. Their inclusion in a combined formulation does not establish synergistic activity, safety, efficacy, or therapeutic utility.

FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN OR VETERINARY USE.

This material is intended exclusively for laboratory, analytical, and investigational research. It is not a dietary supplement, food, drug, or therapeutic product and is not intended for ingestion or administration.